Making news

Events & publications

January 11, 2022

Tranquis Therapeutics presents at the Biotech Showcase, January 2022 – JPM Conference

November 12, 2021

ALS News Today: TQS-168 Found to Reduce Inflammation, Extend Survival in Mice

November 08, 2021

The small molecule myeloid cell modulator TQS 168 normalizes the inflammatory phenotype of immune cells from ALS patients and extends survival in the SOD1*G93A ALS mouse model
E. Chavez Juan, D. Ness, B. Ajami, N. Schwartz, J. Hannestad, S. Kakkar and H. Lancero. Presented at Neuroscience, November 8-11, 2021.